<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04638023</url>
  </required_header>
  <id_info>
    <org_study_id>FF-2017-372</org_study_id>
    <nct_id>NCT04638023</nct_id>
  </id_info>
  <brief_title>Arabin Pessary in Singleton Pregnancy</brief_title>
  <official_title>Arabin Pessary Use in Women at High Risk for Preterm Birth: 7 Years' Experience in a Single Tertiary Centre</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National University of Malaysia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National University of Malaysia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This was a retrospective study sharing the experience of women high risk for spontaneous&#xD;
      preterm birth managed by Arabin pessary.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study recruitment was from 1st January 2013 until 31st December 2019. Inclusion criteria&#xD;
      were previous mid-trimester miscarriage and/or preterm birth, previous cervical surgery or&#xD;
      short cervical length on routine ultrasound. The primary outcome measure was birth before 34&#xD;
      weeks gestation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2017</start_date>
  <completion_date type="Actual">January 1, 2018</completion_date>
  <primary_completion_date type="Actual">January 1, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Birth at or more than 34 weeks</measure>
    <time_frame>From insertion of the Arabin pessary until birth of the foetus</time_frame>
    <description>Gestation of birth in percentage that occurred at or more than 34 weeks gestation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Type of labour</measure>
    <time_frame>From insertion of the Arabin pessary until birth of the foetus</time_frame>
    <description>Type of labour whether spontaneous or induced</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mode of delivery</measure>
    <time_frame>From onset of labour until birth of the foetus</time_frame>
    <description>Mode of delivery whether vaginal or caesarean section</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Median birth weight</measure>
    <time_frame>At birth</time_frame>
    <description>Median neonatal birth weight in gram</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Admission into neonatal intensive care unit</measure>
    <time_frame>At birth until discharged from the hospital</time_frame>
    <description>The need to admit the neonate to neonatal care intensive care unit at birth</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean cervical length</measure>
    <time_frame>At insertion of the Arabin pessary</time_frame>
    <description>The mean cervical length at insertion of the Arabin pessary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subsequent management</measure>
    <time_frame>From insertion of Arabin pessary until birth of the foetus</time_frame>
    <description>The management of the patients after insertion of the Arabin pessary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Combination with progestogen therapy</measure>
    <time_frame>from insertion of Arabin pessary until birth of the foetus</time_frame>
    <description>Addition of progestogen therapy either vaginally or parenterally</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>From insertion of Arabin pessary until birth of the foetus</time_frame>
    <description>Antenatal complications such as diabetes, hypertension and rupture of membranes</description>
  </secondary_outcome>
  <enrollment type="Actual">58</enrollment>
  <condition>Previous Mid Trimester Miscarriage</condition>
  <condition>Previous Preterm Birth</condition>
  <condition>Previous Cervical Surgery</condition>
  <condition>Short Cervix on Ultrasound</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Arabin pessary</intervention_name>
    <description>Arabin pessary was inserted intravaginally electively in women with cervical insufficiency (history based) or as emergency in those with short cervix on ultrasound.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All women high risk for spontaneous preterm birth who were managed with Arabin pessary were&#xD;
        included.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  all women high risk for spontaneous preterm birth&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  had Arabin insertion elsewhere&#xD;
&#xD;
          -  delivered elsewhere&#xD;
&#xD;
          -  incomplete record&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Females only</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rahana Abd Rahman</last_name>
    <role>Principal Investigator</role>
    <affiliation>UKM</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National University of Malaysia</name>
      <address>
        <city>Cheras</city>
        <state>Kuala Lumpur</state>
        <zip>56000</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Malaysia</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 15, 2020</study_first_submitted>
  <study_first_submitted_qc>November 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 20, 2020</study_first_posted>
  <last_update_submitted>November 20, 2020</last_update_submitted>
  <last_update_submitted_qc>November 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National University of Malaysia</investigator_affiliation>
    <investigator_full_name>Rahana Abd Rahman</investigator_full_name>
    <investigator_title>Assoc. Prof.</investigator_title>
  </responsible_party>
  <keyword>Arabin pessary, spontaneous preterm birth</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
    <mesh_term>Abortion, Spontaneous</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Methodology</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

